Clinical Trial Update: A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome [NA]

View source ↗

Summary

This document provides an update on a multi-centre, double-blind, randomized, placebo-controlled trial evaluating the combination of lopinavir/ritonavir plus ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome

Drugs mentioned

• Copegus (ribavirin)
• Kaletra (lopinavir)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Severe Acute Respiratory Syndrome | NA | Status: UNKNOWN